Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: Correlation with clinical disease stages
- 1 January 2002
- journal article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 35 (1) , 190-198
- https://doi.org/10.1053/jhep.2002.30293
Abstract
Hepatitis C virus (HCV) is the leading cause of chronic hepatitis, affecting approximately 2% of the world' population. The immune mechanisms responsible for the highly variable natural history in a given individual are unknown. We used a multiparameter flow cytometric technique to functionally and phenotypically characterize HCV-specific effector T cells in the peripheral blood of 32 individuals with different stages of hepatitis C disease (resolved, mild chronic, advanced chronic) and normal controls. We found the highest frequencies of virus-specific effector cells with an activated memory phenotype (CD45RO+CD69+) in subjects who had resolved HCV infection, either spontaneously or with antiviral therapy. Effector cells from patients with resolved infection produced Th1 type cytokines following stimulation with nonstructural antigens (NS3 and NS4), whereas effector cells from chronically infected patients produced Th1 type cytokines predominantly following stimulation with the HCV core antigen. Stimulation with superantigen staphylococcal enterotoxin (SEB) induced the same levels of cytokine production in the different patient groups. Among the HCV-seropositive patients, viral load inversely correlated with the Th1 effector cell response to NS3. Interleukin (IL)-4 was produced only in response to the control antigens, but not in response to the HCV recombinant proteins. Taken together, these findings suggest that a vigorous HCV-specific CD4+ Th1 response, particularly against the nonstructural proteins of the virus, may be associated with viral clearance and protection from disease progression. Prospective studies using this new flow cytometric assay will be required to determine whether antiviral therapy modifies the frequency, specificity, and function of these virus-specific effector cells.Keywords
Funding Information
- Research Enhancement Award Program
- Veterans Affairs, Washington, D.C.
- H.R.R.
- National Institutes of Health
- The Portland VA Medical Center
This publication has 35 references indexed in Scilit:
- Primer on Hepatitis C for Hospital Epidemiologists •Infection Control & Hospital Epidemiology, 2000
- Detection of Hepatitis C Virus in Paraffin–Embedded Liver Biopsies of Patients Negative for Viral Rna in SerumHepatology, 1999
- The cellular immune responses induced in the follow-up of interferon-α treated patients with chronic hepatitis C may determine the therapy outcomeJournal of Hepatology, 1998
- Prediction of response during interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: A comparisonHepatology, 1997
- Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency.Journal of Clinical Investigation, 1997
- Cytotoxic T Lymphocyte Response and Viral Load in Hepatitis C Virus InfectionHepatology, 1997
- Strange brew: T cells in the liverImmunology Today, 1996
- Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.Journal of Clinical Investigation, 1996
- Compartmentalization of T lymphocytes to the site of disease: intrahepatic CD4+ T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C.The Journal of Experimental Medicine, 1993
- Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assayJournal of General Virology, 1993